CODX logo

Co-Diagnostics (CODX) Cash From Financing

Annual CFF

-$1.36 M
+$12.67 M+90.28%

December 31, 2023

Summary

Performance

1-Year Change

+90.28%

3-Year Change

-106.91%

5-Year Change

-172.69%

15-Year Change

-122.98%

CODX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.78%
CODX annual cash flow from financing activities is higher than 21.78% of companies in Healthcare sector

High & Low

All-time High

$19.74 M
CODX annual cash flow from financing activities is currently -106.91% below its historical high of $19.74 million

3-Year Low

-$14.03 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CODX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
CODX next annual earnings announcement is scheduled for Mar 14, 2025

OtherCODXcash flowmetrics:

Annual CFI

$15.39 M
CODX annual cash flow from investing activities is $15.39 million

Annual CFO

-$22.08 M
CODX annual cash flow from operations is -$22.08 million

Annual FCF

-$23.45 M
CODX annual free cash flow is -$23.45 million

Annual CAPEX

$1.37 M
CODX annual capital expenditures is $1.37 million

Quarterly CFF

$0.00
$0.000.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

+100%

CODX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.62%
CODX quarterly cash flow from financing activities is higher than 45.62% of companies in Healthcare sector

High & Low

All-time High

$18.06 M
CODX quarterly cash flow from financing activities is currently -100.00% below its historical high of $18.06 million

3-Year Low

-$10.39 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CODX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CODX next earnings announcement is scheduled for Mar 14, 2025

OtherCODXcash flowmetrics:

Quarterly CFI

$4.17 M
CODX quarterly cash flow from investing activities is $4.17 million

Quarterly CFO

-$7.23 M
CODX quarterly cash flow from operations is -$7.23 million

Quarterly FCF

-$7.40 M
CODX quarterly free cash flow is -$7.40 million

Quarterly CAPEX

$174.40 K
CODX quarterly capital expenditures is $174.40 thousand

TTM CFF

-$159.70 K
+$166.30 K+51.01%

September 30, 2024

Summary

Performance

3-Month Change

+51.01%

1-Year Change

+88.29%

3-Year Change

+88.29%

5-Year Change

+88.29%

CODX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

23.38%
CODX TTM cash flow from financing activities is higher than 23.38% of companies in Healthcare sector

High & Low

All-time High

$19.74 M
CODX TTM cash flow from financing activities is currently -100.81% below its historical high of $19.74 million

3-Year Low

-$14.67 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CODX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CODX next earnings announcement is scheduled for Mar 14, 2025

OtherCODXcash flowmetrics:

TTM CFI

$26.42 M
CODX TTM cash flow from investing activities is $26.42 million

TTM CFO

-$25.70 M
CODX TTM cash flow from operations is -$25.70 million

TTM FCF

-$26.84 M
CODX TTM free cash flow is -$26.84 million

TTM CAPEX

$1.14 M
CODX TTM capital expenditures is $1.14 million

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CODX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+90.3%+100.0%+88.3%
3 y3 years-106.9%+100.0%+88.3%
5 y5 years-172.7%+100.0%+88.3%

CODX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-402.8%+90.3%-100.0%+100.0%-135.4%+98.9%
5 y5-year-106.9%+90.3%-100.0%+100.0%-100.8%+98.9%
alltimeall time-106.9%+90.3%-100.0%+100.0%-100.8%+98.9%

Co-Diagnostics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
-$159.70 K(-51.0%)
Jun 2024
-
$0.00(0.0%)
-$326.00 K(-63.0%)
Mar 2024
-
$0.00(-100.0%)
-$881.70 K(-35.4%)
Dec 2023
-$1.36 M(-90.3%)
-$159.70 K(-4.0%)
-$1.36 M(-43.7%)
Sep 2023
-
-$166.30 K(-70.1%)
-$2.42 M(-80.9%)
Jun 2023
-
-$555.70 K(+15.2%)
-$12.65 M(-13.7%)
Mar 2023
-
-$482.20 K(-60.4%)
-$14.67 M(+4.5%)
Dec 2022
-$14.03 M(-3215.9%)
-$1.22 M(-88.3%)
-$14.03 M(+9.5%)
Sep 2022
-
-$10.39 M(+304.2%)
-$12.82 M(+430.5%)
Jun 2022
-
-$2.57 M(-1814.4%)
-$2.42 M(-635.2%)
Mar 2022
-
$150.00 K(>+9900.0%)
$451.40 K(+0.2%)
Dec 2021
$450.40 K(-97.7%)
$0.00(-100.0%)
$450.40 K(-54.6%)
Sep 2021
-
$5500.00(-98.1%)
$993.00 K(-21.3%)
Jun 2021
-
$295.90 K(+98.6%)
$1.26 M(-31.0%)
Mar 2021
-
$149.00 K(-72.5%)
$1.83 M(-90.7%)
Dec 2020
$19.74 M
$542.60 K(+97.7%)
$19.74 M(+2.8%)
Sep 2020
-
$274.50 K(-68.2%)
$19.20 M(+1.5%)
Jun 2020
-
$863.50 K(-95.2%)
$18.93 M(+4.8%)
DateAnnualQuarterlyTTM
Mar 2020
-
$18.06 M(>+9900.0%)
$18.06 M(+206.0%)
Dec 2019
$5.90 M(+214.6%)
$0.00(0.0%)
$5.90 M(+0.4%)
Sep 2019
-
$0.00(0.0%)
$5.88 M(-24.4%)
Jun 2019
-
$0.00(-100.0%)
$7.78 M(0.0%)
Mar 2019
-
$5.90 M(<-9900.0%)
$7.78 M(+314.7%)
Dec 2018
$1.88 M(-68.4%)
-$22.90 K(-101.2%)
$1.88 M(-1.2%)
Sep 2018
-
$1.90 M(>+9900.0%)
$1.90 M(-68.7%)
Jun 2018
-
$0.00(0.0%)
$6.06 M(+1.4%)
Mar 2018
-
$0.00(0.0%)
$5.98 M(+0.7%)
Dec 2017
$5.94 M(+159.3%)
$0.00(-100.0%)
$5.94 M(-20.2%)
Sep 2017
-
$6.06 M(-7208.1%)
$7.44 M(+330.4%)
Jun 2017
-
-$85.30 K(+105.5%)
$1.73 M(-14.7%)
Mar 2017
-
-$41.50 K(-102.8%)
$2.03 M(-11.4%)
Dec 2016
$2.29 M(+56.8%)
$1.51 M(+330.3%)
$2.29 M(+192.2%)
Sep 2016
-
$350.00 K(+63.9%)
$783.50 K(+80.7%)
Jun 2016
-
$213.50 K(-3.0%)
$433.50 K(+97.0%)
Mar 2016
-
$220.00 K
$220.00 K
Dec 2015
$1.46 M
-
-

FAQ

  • What is Co-Diagnostics annual cash flow from financing activities?
  • What is the all time high annual CFF for Co-Diagnostics?
  • What is Co-Diagnostics annual CFF year-on-year change?
  • What is Co-Diagnostics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Co-Diagnostics?
  • What is Co-Diagnostics quarterly CFF year-on-year change?
  • What is Co-Diagnostics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Co-Diagnostics?
  • What is Co-Diagnostics TTM CFF year-on-year change?

What is Co-Diagnostics annual cash flow from financing activities?

The current annual CFF of CODX is -$1.36 M

What is the all time high annual CFF for Co-Diagnostics?

Co-Diagnostics all-time high annual cash flow from financing activities is $19.74 M

What is Co-Diagnostics annual CFF year-on-year change?

Over the past year, CODX annual cash flow from financing activities has changed by +$12.67 M (+90.28%)

What is Co-Diagnostics quarterly cash flow from financing activities?

The current quarterly CFF of CODX is $0.00

What is the all time high quarterly CFF for Co-Diagnostics?

Co-Diagnostics all-time high quarterly cash flow from financing activities is $18.06 M

What is Co-Diagnostics quarterly CFF year-on-year change?

Over the past year, CODX quarterly cash flow from financing activities has changed by +$159.70 K (+100.00%)

What is Co-Diagnostics TTM cash flow from financing activities?

The current TTM CFF of CODX is -$159.70 K

What is the all time high TTM CFF for Co-Diagnostics?

Co-Diagnostics all-time high TTM cash flow from financing activities is $19.74 M

What is Co-Diagnostics TTM CFF year-on-year change?

Over the past year, CODX TTM cash flow from financing activities has changed by +$1.20 M (+88.29%)